Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiyo Yakuhin Voluntarily Recalls 10,080 Frazemicin-S Injection Kits

This article was originally published in PharmAsia News

Executive Summary

Japanese generic drug maker Taiyo Yakuhin voluntarily recalls 10,080 Frazemicin-S (fosfomycin) intravenous 2g kit, because the kit was mistakenly mounted with Indast (imipenem cilastatin) 0.5g kit bottles. The recall items had been distributed to 81 medical facilities nationwide from August to December. The company was alerted to the error by one medical facility who reported a color change in the liquid. According to Taiyo, there are currently no reports of recalled drug administration, and no damage reports. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel